T 2199/22 (PUFA and MK-7/LESAFFRE) of 16.07.2024

European Case Law Identifier: ECLI:EP:BA:2024:T219922.20240716
Date of decision: 16 July 2024
Case number: T 2199/22
Petition for review of: -
Application number: 07765188.3
IPC class: A61K 35/60 A61P 19/00 A61K 31/232 A61K 31/231 A61P 9/00 A61K 31/122
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: Pharmaceutical and nutraceutical products comprising vitamin K2
Applicant name: Lesaffre et Compagnie
Opponent name: Kappa Bioscience As
Board: 3.3.04
Headnote: -
Relevant legal provisions: European Patent Convention Art 100(c)European Patent Convention Art 123(2)European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 13(2)
Keywords: Grounds for opposition - added subject-matter (yes)
Grounds for opposition - insufficiency of disclosure (yes)
Amendments - added subject-matter (yes)
Amendment after summons - exceptional circumstances (no)
Catchword: -
Cited cases: T 0609/02 T 1599/06 T 0966/18
Citing cases: -

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.